Business · 26/02/2018

FDA to Host Public Meeting on Complex Innovative Designs in Clinical Trials

The Food and Drug Administration is requesting public input on the use of complex innovative designs in clinical trials to inform regulatory decision making, as part of a guidance document required by the 21st Century Cures Act, and a pilot program.